Contact us
닫기
Article Search
닫기

Microbiology and Biotechnology Letters

보문(Article)

View PDF

Enzymes and Bioactive Compounds

Microbiol. Biotechnol. Lett. 2014; 42(4): 331-338

https://doi.org/10.4014/kjmb.1403.03003

Received: March 10, 2014; Accepted: September 25, 2014

점액세균 Myxococcus stipitatus KYC4013에 의한 생리활성물질 생산

Production of Bioactive Substances by a Myxobacterium Myxococcus stipitatus KYC4013

Dongju An 1, Soohyun Park 1, Jong Suk Lee 2 and Kyungyun Cho 1*

1Department of Biotechnology, Hoseo University, Asan 336-795, Republic of Korea, 2Gyeonggi Bio Center, Gyeonggi Institute of Science & Technology Promotion, Suwon 443-270, Republic of Korea

Abstract

Go to

Myxococcus stipitatus KYC4013 extract exhibited the most potent antifungal activity among the extracts of 207 Myxococcus strains isolated in Korea. High-resolution LC-MS analysis revealed that M. stipitatus KYC4013 produces five antifungal substances and three other secondary metabolites that were predicted to be melithiazol and phenalamide derivatives, respectively. The putative melithiazol derivatives were best produced in CYS medium and the putative phenalamide derivatives were best produced in VY3 medium.

Keywords: Myxococcus stipitatus, myxobacteria, melithiazol, phenalamide

References

Go to
  1. Ahn J-W, Kim B-W. 2002. Isolation and in vivo activities of antifungal compounds from Myxococcus sp. JW154 (Myxobacteria). Korean J. Microbiol. Biotechnol. 30: 162-166.
  2. Ahn J-W, Choi S-U, Kwon HJ. 2002. Isolation and properties of cytotoxic polyene antibiotics produced by Myxococcus stipitatus JW117. Korean J. Microbiol. Biotechnol. 30: 157-161.
  3. Garcia R, Gerth K, Stadler M, Jr Dogma IJ, Müller R. 2010. Expanded phylogeny of myxobacteria and evidence for cultivation of the ‘unculturables’. Mol. Phylogenet. Evol. 57: 878887.
  4. Gerth K, Pradella S, Perlova O, Beyer S, Müller R. 2003. Myxobacteria: proficient producers of novel natural products with carious biological activities-past and future biotechnological aspects with the focus on the genus Sorangium. J. Biotech. 106: 233-253.
  5. Huntley S, Kneip S, Treuner-Lange A, Søgaard-Andersen L. 2013. Complete genome sequence of Myxococcus stipitatus strain DSM 14675, a fruiting myxobacterium. Genome Announc. 1: e0010013.
  6. Kim YJ, Furihata K, Yamanaka S, Fudo R, Seto H. 1991. Isolation and structural elucidation of stipiamide, a new antibiotic effective to multidrug-resistant cancer cells. J. Antibiot. 44:553-556.
  7. Kim YS, Bae WC, Back SJ. 2003. Bioactive substances from myxobacteria. Korean J. Microbiol. Biotechnol. 31: 1-12.
  8. Li Z-F, Li X, Liu H, Liu X, Han K, Wu Z-H, et al. 2011. Genome sequence of the halotolerant marine bacterium Myxococcus fulvus HW-1. J. Bacteriol. 193: 5015-5016.
  9. Reichenbach H. 2005. Myxococcales. pp. 1059-1144. In Brenner DJ, Krieg NR, Staley JT, Garrity GM (ed.), Bergey’s Manual of systematic Bacteriology, 2nd ed. Bergey’s Manual Trust, East Lansing, MI, USA.
  10. Reichenbach H, Hofle G. 1999. Myxobacteria as producers of secondary metabolites. pp. 149-179. In Grabley S, Thiericke R (ed.), Drug Discovery from Nature, Springer Verlag, Berlin.
  11. Reichenbach H, Dworkin M. 1992. The myxobacteria. pp. 3416-3487. In Balows A, Trüper HG, Dworkin M, Harder W, Schleifer K-H (ed.), The Prokaryotes, 2nd ed., vol. IV, Springer Verlag, New York.
  12. Sasse F, Böhlendorf B, Herrmann M, Kunze B, Forche E, Steinmetz H, et al. 1999. Melithiazols, new beta-methoxyacry-late inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties. J. Antibiot. 52: 721-729.
  13. Shi W, Köhler T, Zusman DR. 1994. Motility and chemotaxis in Myxococcus xanthus. Methods Mol. Genet. 3: 258-269.
  14. Shin H, Youn J, An D, Cho K. 2013. Production of antimicrobial substances by strains of myxobacteria Corallococcus and Myxococcus. Korean J. Microbiol. Biotechnol. 41: 44-51.
  15. Trowitzsch-Kienast W, Forche E, Wray V, Reichenbach H, Jurkiewicz E, Hunsmann G, et al. 1992. Antibiotika aus gleitenden bakterien, 45. Phenalamide, neue HIV-1-inhibitoren aus Myxococcus stipitatus Mx s40. Liebigs Annalen der Chemie. 1992: 659-779.
  16. Weinig S, Hecht HJ, Mahmud T, Müller R. 2003. Melithiazol biosynthesis: further insights into myxobacterial PKS/NRPS systems and evidence for a new subclass of methyl transferases. Chem. Biol. 10: 939-952.
  17. Weissman KJ, Müller R. 2009. A brief tour of myxobacterial secondary metabolism. Bioorg. Med. Chem. 17: 2121-2136.
  18. Weissman KJ, Müller R. 2010. Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat. Prod. Rep. 27: 1276-1295.
  19. Wenzel SC, Müller R. 2009. The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat. Prod. Rep. 26: 1385-1407.
  20. Zusman DR, Scott AE, Yang Z, Kirby JR. 2007. Chemosensory pathways, motility and development in Myxococcus xanthus. Nat. Rev. Microbiol. 5: 862-872.

Article Tools

Starts of Metrics

Share this article on :

Related articles in MBL

Most Searched Keywords ?

What is Most Searched Keywords?

  • It is most registrated keyword in articles at this journal during for 2 years.